Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Transgene sells Tasly its stake in Transgene Tasly (Tianjin) JV

Executive Summary

Transgene SA is selling Tasly Biopharmaceuticals Co. Ltd. its 50% stake of their equally owned Transgene Tasly (Tianjin) BioPharmaceutical Co. virus-based immunotherapies joint venture (formed in 2010), giving Tasly a 100% ownership of the JV.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Intra-Biotech Deal
    • Partial Acquisition
    • Payment Includes Stock

Related Companies